Siemens Healthineers is enabling healthcare providers worldwide to meet their current challenges and to excel in their respective environments. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. Siemens Healthineers has about 46,000 employees worldwide. Further information is available at www.siemens.com/healthineers
Siemens Healthineers has local sales and service personnel in all business areas close to local customers. With approx. 550 employees in the Nordic countries (incl. the Baltic States), we strive to be a trusted partner for our customers, with in-depth knowledge on specific challenges and opportunities for healthcare providers
Mebi AS is a company in Tromp Medical House, which is represented as Hologic distributer in the Nordic and Benelux countries. As a leading global healthcare and diagnostics company, Hologic strive to make advances toward greater certainty for their customers by providing them with cutting-edge technology that makes a real difference. Hologic focuses on women's health through evidence based research and supplies a wide range of market leading products within mammography, biopsy and bone density measurement.
AstraZeneca is one of the world’s largest biopharmaceutical companies. Our aim is to develop and market innovative and cost effective drugs that promote healt and quality of life.
Oncology is one of our priority areas. Future cancer treatment is moving towards a targeted treatment of the underlying mechanisms of the disease. AstraZeneca is working to develop targeted medicines for a variety of cancer diagnoses by using various mechanisms. AstraZeneca’s objective is to identify the most effective combinations of specific molecules within immunomodulating cancer treatment. Due to the biological complexity of most types of cancer, combination therapy has proven to be the most effective treatment against cancer
ScreenPoint Medical BV develops deep learning and image analysis technology for automated reading of mammograms and digital breast tomosynthesis. The company is a spin-off from the Radboud University in Nijmegen, The Netherlands and was founded by Michael Brady(Chairman) and Nico Karssemeijer (CEO) in May 2014. Products & Services ScreenPoint’s Transpara™ is an image analytics software for mammograms offering decision support and pre-screening solutions for radiologist and screening organizations. Transpara™ is built on deep learning algorithms. Transpara™ Decision Support provides calcification CAD marks that can be viewed on both the mammography reading station and the Transpara™ Tablet Viewer. While calcifications are marked as in regular CAD systems, no mass marks are shown. Instead, the reader can probe suspicious image regions for decision support. With this approach, information is provided when needed, and does not confront radiologists with unexpected false alarms. The software correlates MLO and CC views when abnormalities are visible in both views. Transpara™ Decision Support also provides predictive values of the ratings provided at the probed locations. Marks at locations that are not probed remain hidden. Transpara™ Pre-Screening automatically selects a large fraction of screening mammograms of women that are highly unlikely to have cancer. Healthcare providers can save costs when these pre-selected mammograms are read by one reader only instead of two, while more attention can be given to exams with a high likelihood of cancer to improve quality.
Sectra assists hospitals throughout the world. The company was founded in 1978, has its head office in Linköping, Sweden, with subsidiaries in 15 countries, and operates through partners worldwide.
Sectra develops and sells IT solutions for the management and communication of all types of medical images—primarily in radiology, mammography, pathology and orthopaedics, as well as other departments where medical images are used. Sectra has a strategic focus on making cancer care more efficient. More than 1,700 hospitals, clinics and imaging centers worldwide use Sectra’s systems daily. This makes Sectra one of the world’s leading providers of IT solutions for managing medical images and patient information. The company commands a market-leading position in Sweden, Norway, the Netherlands and Portugal, holds a prominent position in the UK and is growing in the US. Sectra has delivered some of the largest installations of medical IT systems worldwide and its systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East. For more information, visit www.sectra.com
Royal Philips is a diversified technology company, focused on improving people’s lives through meaningful innovation. Our health care business makes up 42% of our global sales revenue. With a century of history and more than 450 innovative products and services, we are ready to meet today’s challenges in healthcare by creating solutions that deliver better care to more people at lower cost. Our holistic vision of healthcare goes beyond the delivery of care. It includes how we approach creating solutions and why involving our customers as part of the process is so important. Bringing a deep clinical expertise and key insights from data and analytics, we partner with our customers to deliver innovative solutions that really matter. Our more than 37,000 employees, working in 100 countries, are committed to helping you create meaningful moments of care, whether in the hospital room, the living room or the boardroom. See how we are working to create a healthier future together: www.philips.no/healthcare
|Decotron AS has special expertise in sales, support, installation, application, service and maintenance. We deal products from a number of acknowledged international suppliers. Besides combining ergonomics with ease of use, the products in our assortment offer high reliability and excellent image quality.
Our strength lies in the possibilities of finding optimal solutions by choosing from our independent suppliers. This way we can easily find the equipment that best meets the customer's needs.
Our mammography unit Clarity is provided to us by Planmed OY, a company that offers products for mammography and orthopedic imaging that are well-known for imaging performance, user-friendliness and good ergonomics. Since 1989, Planmed systems have provided tools for healthcare professionals in over 70 countries worldwide.
Planmed is strongly committed to improving the early detection of breast cancer. Their mission is to provide top quality imaging systems for mammographic screening and diagnosis. This dedication to mammography has inspired them to constantly develop new, innovative solutions for breast imaging. The novel and elegant Planmed ClarityTM system offers top of the line digital mammography and tomosynthesis with great promise for the future. See more with Clarity!
For more than a century, C. R. Bard, has been at the forefront of developing innovative medical devices that solve the challenges of healthcare professionals and patients.
At Bard Biopsy Systems we are committed to helping physicians deliver uncompromised care for every patient - from breast biopsy to therapy. We understand the challenges
physicians face in delivering superior care for their patients at all stages of treatment. Our technology, service and product development is directed toward finding solutions to
these challenges that make it easier and more efficient for physicians to take patient care to a higher level.
KEBOMED is a leading independent European distributor of medical devices and equipment, with vast clinical experience, and deep knowledge of the local markets. We offer solutions tailored to the specific needs of healthcare professionals, with focus on comfort and safety for both patients and practitioners.
KEBOMED is a supplier of fluoroscopy systems from Fujifilm. Fujifilm was among the first companies to produce radiography equipment in the world, and has developed the new Amulet Innovality mammography screening device, available with tomosynthesis, 3D mammography and biopsy. The system provides excellent images with low doses of radiation, and high patient comfort. The system has brilliant capacity and a smooth workflow, and is the perfect tool for hospitals that rely on high efficiency to handle large flows of patients.
Volpara Solutions’ digital health services enable personalised, high-quality breast cancer screening based on automated, objective measurements of breast density, compression and radiation dose. With its VolparaDensity and cloud-based VolparaEnterprise software, Volpara is the market leader in both breast density analysis and quality and performance analytics for breast imaging centres.
Volpara’s software is the most clinically validated of its kind in the world, featured in over 240 medical publications, and is supported by numerous patents, trademarks and regulatory clearances, notably FDA and CE, as well as a strategic partnership with GE and a collaboration with Microsoft. For more information, visit volparasolutions.com